Clinical Trial Update: RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of RAD001 (everolimus) in combination with docetaxel for metastatic breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• RAD001 (everolimus)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED